Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

How molecular pathology is changing and will change the therapeutics of patients with follicular cell-derived thyroid cancer.

Journal of clinical pathology - 1 May 2009

Couto J Pinto, Prazeres H, Castro P, Lima J, Máximo V, Soares P, Sobrinho-Simões M

Abstract excerpt

Well-differentiated thyroid carcinomas comprise two well-defined histological types: papillary and follicular (PTCs and FTCs, respectively). Despite being derived from the same cell (thyroid follicular cell), these two types of tumour accumulate distinct genetic abnormalities during progression. The molecular pathology of thyroid cancer is now better understood because of our ability to identify RET/PTC...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma, Follicular
Share to Antineoplastic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Papillary

Share to Gene Rearrangement

Share to Proto-Oncogene Proteins B-raf

Share to Proto-Oncogene Proteins c-ret

Share to ras Proteins

Share to Thyroid Neoplasms

Source

Identifiers

PMID: 19147628
DOI: 10.1136/jcp.2008.055343

Genes

BRAF
RET
PAX8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

How molecular pathology is changing and will change the therapeutics of patients with follicular cell-derived thyroid cancer.PMID 19147628Read ↗

Molecular pathology of well-differentiated thyroid carcinomas.Semantic proximity Read ↗

Signaling pathways in follicular cell-derived thyroid carcinomasSemantic proximity Read ↗

Progress in Treating Advanced Thyroid Cancers in the Era of Targeted Therapy.Semantic proximity Read ↗

This is Your Thyroid on Drugs: Targetable Mutations and Fusions in Thyroid Carcinoma.Semantic proximity Read ↗

This is Your Thyroid on Drugs: Targetable Mutations and Fusions in Thyroid Carcinoma.Semantic proximity Read ↗

Genetic Alterations in Poorly Differentiated and Undifferentiated Thyroid CarcinomasSemantic proximity Read ↗

Papillary Thyroid Cancer: Genetic Alterations and Molecular Biomarker InvestigationsSemantic proximity Read ↗

Pathology and genetics of thyroid carcinoma.Semantic proximity Read ↗

Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosisSemantic proximity Read ↗

Well differentiated follicular thyroid neoplasia: impact of molecular and technological advances on detection, monitoring and treatment.Semantic proximity Read ↗

A Narrative Review of Genetic Alterations in Primary Thyroid Epithelial Cancer.Semantic proximity Read ↗

Molecular findings in thyroid tumors: Practical diagnostic, prognostic, and therapeutic insights.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.